Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Pharmaceutics|October 28, 2023
Nucleoside Analog 2',3'-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1Ksenia Glumakova, Georgy Ivanov, Valeria Vedernikova, et al.
Frontiers in Molecular Biosciences|May 22, 2024
Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cellsAlexander Burov, Ekaterina Grigorieva, Timofey Lebedev, et al.
Cancers|January 11, 2025
Association of Proteasome Activity and Pool Heterogeneity with Markers Determining the Molecular Subtypes of Breast CancerIrina Kondakova, Elena Sereda, Evgeniya Sidenko, et al.
Marine Drugs|September 26, 2021
Cytotoxic Marine Alkaloid 3,10-Dibromofascaplysin Induces Apoptosis and Synergizes with Cytarabine Resulting in Leukemia Cell DeathPavel Spirin, Elena Shyrokova, Timofey Lebedev, et al.
Biochemistry and Biophysics Reports|October 14, 2022
PRMT1 is an important factor for medulloblastoma cell proliferation and survivalXiao Gu, Miao He, Timofey Lebedev, et al.
Pharmaceutics|April 26, 2025
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers ApoptosisPavel Spirin, Valeria Vedernikova, Tatsiana Volkava, et al.
Molecular Therapy. Oncology|March 26, 2026
Targeted attack: Harnessing myelin-specific plasmolipin for suppression of neuroblastoma and glioblastomaPavel Spirin, Andrey Shulgin, Timofey Lebedev, et al.
Cells|August 26, 2023
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR PathwaysDmitri Kamashev, Nina Shaban, Timofey Lebedev, et al.
Oncogene|September 24, 2021
Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypesTimofey Lebedev, Elmira Vagapova, Pavel Spirin, et al.
Oncotarget|November 16, 2017
Gene expression and molecular pathway activation signatures of <i>MYCN</i>-amplified neuroblastomasIvan Petrov, Maria Suntsova, Elena Ilnitskaya, et al.
Pageof 3